InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+15.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Mayleben Timothy M, Directeur. Insider active across 3 companies, notably Marinus Pharmaceuticals INC. Aggregated, 8 filings have been published. Split: 2 buys · 0 sell. History available since 4 February 2022. The latest transaction was disclosed on 7 February 2025 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mayleben Timothy M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
4,600 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011242:0
4,980 shares0Common StockSEC:0001415889-24-025070:0
2,300 shares0Common StockSEC:0001415889-24-017639:0
4,600 shares0Common StockSEC:0001415889-24-001595:0
3,600 shares0Common StockSEC:0001415889-23-001552:0
2,750 shares0Common StockSEC:0001104659-22-012791:0
3,600 sharesCommon StockSEC:0001179110-16-018105:0
Canonical exit: 26 Apr 2016 (T+90)
7,200 sharesCommon StockSEC:0001179110-16-017791:0
Canonical exit: 14 Apr 2016 (T+90)
8 of 8 declarations
About Mayleben Timothy M
Timothy M. Mayleben is a Director at Marinus Pharmaceuticals Inc. In this role, he participates in the governance and strategy of the company, contributing to important decision-making. Mayleben brings valuable expertise in the pharmaceutical sector, thereby supporting growth and innovation within the organization. His commitment to operational excellence is an asset for Marinus.
